Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 8;25(1):1002.
doi: 10.1186/s12879-025-11408-1.

Drug resistance among students with pulmonary tuberculosis: a study based on screening in Henan, China

Affiliations

Drug resistance among students with pulmonary tuberculosis: a study based on screening in Henan, China

Jiying Xu et al. BMC Infect Dis. .

Abstract

Background: Tuberculosis (TB) can easily spread among students and can lead to an outbreak once there is an infection in a school. Outbreaks of drug-resistant TB (DR-TB) in schools have occasionally been reported, but the profile of DR-TB in students in a province has rarely been described. This study was conducted to determine the prevalence of DR-TB and factors associated with it in students in Henan Province, China.

Methods: We retrospectively reviewed the data of 3527 pulmonary TB patients among students with culture-confirmed Mycobacterium tuberculosis (M.tb) isolates collected from the Tuberculosis Information Management System of the China Disease Prevention and Control Information System from 2015 to 2021. Prevalence of DR-TB was analyzed. Comparisons between categorical variables were analyzed using the chi-square test or Fisher's exact test as appropriate. Logistic regression models were used to identify the factors associated with DR-TB.

Results: Any DR-, RR (rifampin resistance)- and MDR (multi-drug resistance) -TB rates in students were 10.46%, 7.91% and 6.10%, respectively. And they all showed a downward trend from 2015 to 2021 (p < 0.001). Previously treated cases were 7.30 (95% CI: 5.30, 10.05), 8.60 (95% CI: 6.14,12.14) and 9.43 (95% CI: 6.64,13.40) times more likely than the new cases to be diagnosed with Any DR-TB, RR-TB and MDR-TB, respectively. Patients from schools in the western region of Henan had greater odds of having Any DR- (AOR = 2.06, 95% CI: 1.31, 3.24), RR- (AOR = 2.81, 95% CI: 1.66, 4.76) and MDR-TB (AOR = 2.07, 95% CI: 1.13, 3.80) than those from schools in the northern region. Males had a 1.40-fold (95% CI: 1.11, 1.78), 1.34-fold (95% CI: 1.02, 1.75) greater likelihood of being diagnosed with Any DR- and RR-TB, respectively. The risk of being diagnosed with MDR-TB was 1.42 (95% CI: 1.00, 2.02) times greater in students migrant between prefectures of the province than in the locals.

Conclusion: The prevalence of DR-TB among students with PTB in Henan, China, significantly decreased from 2015 to 2021. Previous treated cases and those in west-region schools in Henan were at greater risk of being diagnosed with Any DR-, RR- and MDR-TB. In addition, males were more likely to be diagnosed with Any DR- and RR-TB. It requires further study that whether those who migrated between prefectures of the province were more likely to be diagnosed with MDR-TB.

Keywords: Drug resistance; Student; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Human Ethics and Consent to Participate: Not applicable. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Study population of drug resistance among students with pulmonary tuberculosis in Henan, China, from 2015 to 2021

Similar articles

References

    1. World Health Organization. Global tuberculosis report 2023. Geneva: 2023.
    1. Singh R, Dwivedi SP, Gaharwar US, Meena R, Rajamani P, Prasad T. Recent updates on drug resistance in Mycobacterium tuberculosis. J Appl Microbiol. 2020;128(6):1547–67. - PubMed
    1. Wang Shengfen Z, Yang O, Xichao, et al. Drug resistance of tuberculosis in china: analysis of National drug resistance surveillance data of tuberculosis in 2018 [J]. Chin J Antituberc. 2022;44(11):1141–7.
    1. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no.4. WHO/HTM/TB/2008.394. Geneva, Switzerland: World Health Organization; 2008.
    1. World Health Organization. Anti-tuberculosis drug resistance in the world. Report no.3. WHO/HTM/TB/2004.343. Geneva, Switzerland: World Health Organization; 2004.

MeSH terms

Substances

LinkOut - more resources